+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Fanconi Anemia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Fanconi Anemia Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Bispecific Antibodies - Global Strategic Business Report 2026 - Product Thumbnail Image

Bispecific Antibodies - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 104 Pages
  • Global
From
From
From
From
From
Metastatic Breast Cancer Treatment Market Report 2026 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Emicizumab Injection Market - Global Forecast 2026-2032 - Product Thumbnail Image

Emicizumab Injection Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
From
Lupus Nephritis - Pipeline Insight, 2026 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
Loading Indicator